Sunshine Biopharma Inc. Ratios

Ratios Dec2010 Dec2011 Dec2012 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 12.55%47.68%63.80%48.42%39.04%34.61%30.60%
EBT Margin 55,656.60%-63,670.26%2,959.35%917.70%-296.50%-5,104.18%-3,898.74%-5,444.41%-610.07%-17.06%-15.40%
EBIT Margin 55,556.60%-45,683.67%2,859.35%817.70%-260.85%-3,037.91%-807.83%-1,068.24%-621.33%-19.86%-16.67%
EBITDA Margin 55,556.60%-96,731.15%10,068.62%992.21%-483.09%-7,854.97%-3,898.21%-5,435.54%-611.18%-16.49%-19.10%
Operating Margin 55,556.60%-45,683.67%2,859.35%817.70%-260.85%-3,037.91%-807.83%-1,068.24%-621.33%-19.86%-16.67%
Net Margin 55,656.60%-63,670.26%10,067.62%992.32%-482.15%-7,860.85%-3,898.74%-5,444.41%-615.44%-18.70%-14.72%
FCF Margin 30,900.47%-51,079.45%914.49%522.03%-118.89%-2,351.49%-922.13%-800.75%-125.24%-36.76%-40.68%
Efficiency
Inventory Average 0.02M0.06M1.70M4.51M8.51M
Assets Average 0.16M0.37M0.16M0.70M0.62M0.57M1.62M15.72M28.30M28.95M
Equity Average 0.15M-0.40M-0.39M-0.31M-0.40M-0.85M-0.37M10.92M21.42M22.35M
Invested Capital 0.20M0.10M-0.60M-0.21M-0.57M-0.03M-0.74M-0.01M0.21M21.63M21.21M23.50M
Asset Utilization Ratio -0.09-0.650.640.030.120.140.280.851.20
Leverage & Solvency
Interest Coverage Ratio -555.57-2.54-28.59-8.18-7.32-5.54-3.43-7.42-685.09-34.85-662.43
Debt to Equity -0.14-5.57-0.998.98
Debt Ratio 0.310.270.910.86
Equity Ratio 0.950.97-0.89-3.26-2.23-0.05-7.49-0.910.100.740.780.77
Times Interest Earned -555.57-2.54-28.59-8.18-7.32-5.54-3.43-7.42-685.09-34.85-662.43
Valuation
Enterprise Value -0.16M-0.06M-0.05M-0.06M-0.11M-0.11M-0.05M-1.00M-2.05M-7.37M-9.32M-3.69M
Market Capitalization 14.46M6.97M6.00M
Return Ratios
Return on Sales 556.57%-636.70%29.59%9.18%-2.97%-27.57%-38.99%-54.44%-6.15%-0.19%-0.15%
Return on Capital Employed -10.48%1.45%5.54%3.04%1.20%-1.59%-3.07%-0.21%-0.26%
Return on Invested Capital -0.25%
Return on Assets -2.79%-5.98%-1.89%-0.94%-4.87%-7.66%-1.70%-0.16%-0.18%
Return on Equity 2.55%2.46%4.22%1.47%3.29%33.47%-2.45%-0.21%-0.23%